Literature DB >> 10397168

Control of tumor development by intratumoral cytokines.

F Pages1, V Vives, C Sautès-Fridman, F Fossiez, A Berger, P H Cugnenc, E Tartour, W H Fridman.   

Abstract

The local immune reactions may influence the clinical outcome of human tumors. In carcinoma of the cervix, high gene expression of IL6 with tumor invasiveness whereas lack of gene expression of IFNbeta is correlated with poor prognosis. In colorectal cancer, lack of expression of IFNbeta is associated with the presence of distant metastasis and poor survival. The production of IL17 and IL18, inducers of IL6 and IFNbeta respectively is regulated in these tumors and may control the levels of the effector cytokines, i.e. IL6 and IFNbeta. The mechanisms by which these cytokines act are linked to the recruitment of effector cells such as macrophages.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10397168     DOI: 10.1016/s0165-2478(99)00042-5

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  4 in total

1.  Retinoic acid-related orphan receptor C isoform 2 expression and its prognostic significance for non-small cell lung cancer.

Authors:  Qi Huang; Jinshuo Fan; Xin Qian; Zhilei Lv; Xiuxiu Zhang; Jieli Han; Feng Wu; Caiyun Chen; Jiao Du; Mengfei Guo; Guorong Hu; Yang Jin
Journal:  J Cancer Res Clin Oncol       Date:  2015-08-30       Impact factor: 4.553

2.  IL-17 increased the production of vascular endothelial growth factor in rheumatoid arthritis synoviocytes.

Authors:  S Ryu; J H Lee; S I Kim
Journal:  Clin Rheumatol       Date:  2005-09-15       Impact factor: 2.980

Review 3.  Steroid receptor coactivator-3 as a potential molecular target for cancer therapy.

Authors:  Jean Ching-Yi Tien; Jianming Xu
Journal:  Expert Opin Ther Targets       Date:  2012-08-27       Impact factor: 6.902

4.  Local and distant recurrences in rectal cancer patients are predicted by the nonspecific immune response; specific immune response has only a systemic effect--a histopathological and immunohistochemical study.

Authors:  I D Nagtegaal; C A Marijnen; E K Kranenbarg; A Mulder-Stapel; J Hermans; C J van de Velde; J H van Krieken
Journal:  BMC Cancer       Date:  2001-07-16       Impact factor: 4.430

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.